NEWS
Entrepreneurial support for Stem Cell-Spinout from UCPH
The startup company PanCryos, which is a spinout from the Novo Nordisk Foundation Center for Stem Cell Biology at University of Copenhagen, receives a convertible loan of DKK 10 M. as well as entrepreneurial support from BioInnovation Institute, as they are enrolled...
BII funds stem cell therapy start-up with DKK 10M
The start-up PanCryos joins the Creation House program with a convertible loan of DKK 10M. Soon the company which is led by CEO and co-founder Dr. Jacqueline Ameri will move into BioInnovation Institute to continue the work on developing a new treatment for diabetes...
Immature cells zap around before settling down
Stem cells are already being used in combating previously untreatable diseases. Nevertheless, stem cells are not delivering their full potential because the production of specific cell types from stem cells cannot yet be managed. Researchers have now...
Time to cure type 1 diabetes: Danish researchers among the leaders
People with type 1 diabetes strongly depend on injecting synthetically produced insulin. However, this situation may change within a few years. Today, researchers can already recreate insulin-producing beta cells from stem cells, which can be implanted in people with...
PanCryos at Nasdaq closing bell ceremony in New York with the Nordic-American Life Sciences Conference
Biomarker May Allow for Type 1 Diabetes Stem Cell Therapy
Scientists in Denmark say they’re one step closer to developing a stem-cell therapy that could eventually allow patients with type 1 diabetes (T1D) to be insulin independent again. Read more...
Researchers develop new way to develop purer insulin-producing stem cells
Researchers from Denmark are developing ways to make lab-grown insulin-producing cells safer. The future of type 1 diabetes treatment is likely to come from living cells that can produce and release insulin inside the person's body. In recent years, scientists have...
Pitching at biotech event, Berlin
LABIOTECH.EU Labiotech Refresh is an annual biotech event taking place in Berlin. Pancryos' CEO Jacqueline Ameri pitching at...
Nordic mentor network for entrepreneurship welcomes Pancryos
NOME (The Nordic mentor network for entrepreneurship) has engaged with four exciting life science startups. These companies come from a diverse range of technologies, personalized medicine in cancer, a diagnostic for joint damage, a stem cell therapy in diabetes and...
Towards a Safe and Scalable Cell Therapy for Type 1 Diabetes by Simplifying Beta Cell Differentiation
HEALTHSCIENCES EUROSTEMCELL.ORG Stem cell research More than 36 million people globally are affected by type 1 diabetes (T1D), a lifelong disorder where insulin producing cells are attacked and destroyed by the immune system resulting in deficient insulin production...